Drugmaker Novartis announced it’s cutting more than 2,000 jobs — most of them in Europe — as part of a global restructuring. The company plans to focus on producing and selling more innovative drugs, but these specified medicines require lots of research and carry higher price tags.
Click the audio player above to hear the full story.
3 hours ago25:16
10 hours ago5:54
15 hours ago8:19
5 days ago27:11
7 days ago12:18
4 months ago24:33